Shearman & Sterling is advising CVS on its US$69 billion acquisition of Aetna. This industry-transforming transaction is expected to provide more integrated and efficient healthcare services for consumers and health professionals.
Under the terms of the agreement, Aetna shareholders will receive US$207 per share, comprising US$145 in cash and US$62 in CVS stock. Including the assumption of Aetna’s net debt, the total value of the deal is US$77 billion. The deal is subject to approval by CVS Health and Aetna shareholders, regulatory approvals and other customary closing conditions and is expected to close in the second half of 2018. Upon closing, CVS Health shareholders will own approximately 78% of the combined company and Aetna shareholders will own approximately 22%.
The Shearman & Sterling team was led by partners Creighton Condon, Robert Katz, Dan Litowitz, Doreen Lilienfeld, Stephen Giove, Lona Nallengara, Gus Atiyah, Alan Goudiss, Mallory Brennan, Larry Crouch, Ethan Harris and Jordan Altman. The team also included associates Cody Wright, Katie Butler, Christopher Tomlinson, Kaitlin Bruno, Kotoe Oshima, Rupa Briggs, Daniel Yao, Gina Lee, Matthew Weston, Jai Garg, Barbara Zylberg, Arman Naraghi-Pour, Magnus Wieslander, David Selesnick, Ryan Bray and Eric Grosshandler.
Full Content: Shearman & Sterling
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Probes Lindab’s Acquisition of HAS-Vent Amid Fears of Market Monopoly
Apr 28, 2024 by
CPI
Shein Faces EU Regulations Over User Data
Apr 28, 2024 by
CPI
Google Fights Back Against US Antitrust Lawsuit
Apr 28, 2024 by
CPI
US Homeland Security Establishes Blue-Ribbon Board with Tech CEOs to Advise on AI
Apr 28, 2024 by
CPI
FTC Accuses Amazon Executives of Using Disappearing Messaging Apps to Conceal Evidence
Apr 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI